This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakanishi, N Articles by Mitsuhashi, S Search for Related Content PubMed PubMed Citation Articles by Nakanishi, N Articles by Mitsuhashi, S

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1991 December; 35(12): 2562-2567

Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.

Episome Institute, Gunma, Japan.

ABSTRACT

Mechanisms of Staphylococcus aureus resistance to fluoroquinolones were characterized. Subunit A and B proteins of DNA gyrase were partially purified from fluoroquinolone-susceptible strain SA113 and resistant isolate MS16405, which was 250- to 1,000-fold less susceptible to fluoroquinolones such as ciprofloxacin, norfloxacin, ofloxacin, temafloxacin, and sparfloxacin than SA113 was. The supercoiling activity of the gyrase from SA113 was inhibited by the fluoroquinolones, and the 50% inhibitory concentrations of the drugs correlated well with their MICs. In contrast, the gyrase from MS16405 was insensitive to inhibition of supercoiling by all of the quinolones tested, even at 800 micrograms/ml. Combinations of heterologous gyrase subunits showed that subunit A from MS16405 conferred fluoroquinolone resistance, suggesting that an alteration in gyrase subunit A is a cause of the fluoroquinolone resistance in MS16405. Uptake of hydrophilic fluoroquinolones such as ciprofloxacin and norfloxacin by MS16405 was significantly lower than that by SA113. Furthermore, this difference was abolished by the addition of an energy inhibitor, carbonyl cyanide m-chlorophenylhydrazone, suggesting that an alteration in an energy-dependent process, such as an active efflux of hydrophilic quinolones, may lead to decreased drug uptake and hence to increased resistance to fluoroquinolones in MS16405. These findings suggest that the fluoroquinolone resistance in MS16405 is due mainly to an alteration in subunit A of DNA gyrase and may also be associated with an alteration in the drug uptake process.

This article has been cited by other articles:

• Aeschlimann, J. R., Kaatz, G. W., Rybak, M. J. (1999). The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model. J Antimicrob Chemother 44: 343-349 [Abstract] [Full Text]  
• Saiki, A. Y. C., Shen, L. L., Chen, C.-M., Baranowski, J., Lerner, C. G. (1999). DNA Cleavage Activities of Staphylococcus aureus Gyrase and Topoisomerase IV Stimulated by Quinolones and 2-Pyridones. Antimicrob. Agents Chemother. 43: 1574-1577 [Abstract] [Full Text]  
• Aeschlimann, J. R., Dresser, L. D., Kaatz, G. W., Rybak, M. J. (1999). Effects of NorA Inhibitors on In Vitro Antibacterial Activities and Postantibiotic Effects of Levofloxacin, Ciprofloxacin, and Norfloxacin in Genetically Related Strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 43: 335-340 [Abstract] [Full Text]  
• Fournier, B., Hooper, D. C. (1998). Mutations in Topoisomerase IV and DNA Gyrase of Staphylococcus aureus: Novel Pleiotropic Effects on Quinolone and Coumarin Activity. Antimicrob. Agents Chemother. 42: 121-128 [Abstract] [Full Text]